Jessica Merlin received funding for an R01 award, “Opioid therapy for pain in individuals with metastatic cancer: benefits, harms, and stakeholder perspectives,” from NIH/NINR.
Jessica Merlin received funding for an R01 award, “Opioid therapy for pain in individuals with metastatic cancer: benefits, harms, and stakeholder perspectives,” from NIH/NINR.